Evidence map›Paper›PMID 32375250›Full record

ReviewInternational journal of molecular sciences2020

Tumor Endothelial Cell-A Biological Tool for Translational Cancer Research.

Dorcas Akuba-Muhyia Annan, Hiroshi Kikuchi, Nako Maishi, Yasuhiro Hida, Kyoko Hida

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Aberrant tumor vasculature. Facts and pitfalls.Frontiers in pharmacology · 2024
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dorcas Akuba-Muhyia AnnanDepartment of Vascular Biology and Molecular Pathology, Hokkaido University Graduate School of Dental Medicine, Sapporo 060-8586, Japan.
Hiroshi KikuchiDepartment of Renal and Genitourinary Surgery, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan.
Nako MaishiDepartment of Vascular Biology and Molecular Pathology, Hokkaido University Graduate School of Dental Medicine, Sapporo 060-8586, Japan.
Yasuhiro HidaDepartment of Cardiovascular Thoracic Surgery, Hokkaido University Faculty of Medicine, Sapporo 060-8638, Japan.ORCID 0000-0003-1759-4215
Kyoko HidaDepartment of Vascular Biology and Molecular Pathology, Hokkaido University Graduate School of Dental Medicine, Sapporo 060-8586, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Going from

Indexed as

Angiogenesis InhibitorsAnimalsAntineoplastic AgentsEndothelium, VascularHumansNeoplasmsNeovascularization, PathologicTranslational Research, BiomedicalAngiogenesis InhibitorsAntineoplastic Agentsantiangiogenesis drugstranslational researchtumor endothelial cell

Identifiers

PMID32375250
PMCPMC7247330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.